The clinical significance of serum soluble Fas and p53 protein in breast cancer patients: comparison with serum CA 15-3.
about
Symptomatic metastasis prediction with serial measurements of CA 15.3 in primary breast cancer patients.Proapoptotic CD95L levels in normal human serum and sera of breast cancer patients.Predictors of responses to immune checkpoint blockade in advanced melanomaDesign of a universal biointerface for sensitive, selective, and multiplex detection of biomarkers using surface plasmon resonance imaging.Circulating levels and clinical implications of epithelial membrane antigen and cytokeratin-1 in women with breast cancer: can their ratio improve the results?
P2860
The clinical significance of serum soluble Fas and p53 protein in breast cancer patients: comparison with serum CA 15-3.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The clinical significance of s ...... comparison with serum CA 15-3.
@en
The clinical significance of s ...... comparison with serum CA 15-3.
@nl
type
label
The clinical significance of s ...... comparison with serum CA 15-3.
@en
The clinical significance of s ...... comparison with serum CA 15-3.
@nl
prefLabel
The clinical significance of s ...... comparison with serum CA 15-3.
@en
The clinical significance of s ...... comparison with serum CA 15-3.
@nl
P2093
P2860
P1476
The clinical significance of s ...... comparison with serum CA 15-3
@en
P2093
Medhat Anwar
Nadia A Abd El-Monaim
Samia A Ebied
P2860
P2888
P304
P356
10.1007/S12253-012-9512-1
P50
P577
2012-03-17T00:00:00Z